SensoDetect AB (publ)

Trade Venues bolagsanalys uppskattar SensoDetects börsvärde till 1,5 MdSEK enbart för MENA regionen SensoDetect adresserar ett stort samhällsproblem. Genom att ha ändrat affärsmodellen från att tidigare sälja mätutrustningen, till att i stället ta betalt per mätning, skapas potential för tidsmässigt långa kassaflöden. Detta sker samtidigt som kostnaden för att producera utrustningen har minskat kraftigt, vilket skapar bra skalbarhet även vid mindre lyckade marknadslanseringar. För 2024 estimerar vi en omsättning om 12 MSEK, drivet av framför allt “School for all”-projektet. Detta skulle enligt våra prognoser resultera i en mindre rörelseförlust, vilket kan jämföras med att företaget redovisade en omsättning om endast 0,3 MSEK under förra året samt hade ett negativt EBIT-resultat om -7,7 MSEK. För 2025 estimerar vi att omsättningen mer än fördubblas till 29 MEK och att företaget under 2026 når 45 MSEK. Vår prognostiserade tillväxt är driven av de pågående projekten i Kina och framför allt Saudiarabien. Med tanke på affärsmodellens skalbarhet kommer rörelseresultatet vid denna kraftiga försäljningsutveckling, enligt vår modell öka till ca 16 MSEK 2026. Dagens börsvärde om 37 MSEK speglar knappast denna potential där vår prognos på 2026 års resultat indikerar ett P/E-tal om 2. En DCF-värdering visar också på ett mer än dubbelt så högt värde som det nuvarande värdet per aktie. Vi tror att när de första kommersiella avtalen sluts i år kommer att kunna vara startskottet för en ordentlig omvärdering av aktien.*   "Vi i företagsledningen anser att potentialen på längre sikt är betydligt större än så och ser en marknadspotential om över 2 MdSEK enbart för affärsområdet Diagnostics i MENA-regionen. Lyckas vi uppnå en marknadsandel om 20% i regionen år 2028 skulle detta innebära att företaget från detta område genererar årliga intäkter om 400 MSEK." , säger VD Per-Anders (PA) Hedin  Vid användandet av en P/S multipel om 8x skulle detta i sin tur innebära ett potentiellt börsvärde om 1,5 MdSEK (diskonterat till nuvärde), vad avser enbart denna region och affärsområde. Till det kommer så värdet från andra affärsområden samt en förväntad kraftig försäljningsökning i andra regioner. * källa: https://lnkd.in/dc5i5bTA Läs mer om SensoDetect, www.sensodetect.com

FUTURE CLINIC. What does the clinic of the future look like for Sensodetect, in the world? The vision is a modern clinic where all patients, regardless of age or background, experience a welcoming and familiar process. A process that is more sympathetic, empathetic and where waiting times for investigation, diagnosis, medical help, advice and support are significantly shorter. Our technology is documented as a part of this development for better mental health, worldwide. Read more about SensoDetect at our website, www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychatric #testing #neurodivergent #npf #medtech #sensodetect

CARE. The products are used in both private and public care as a complement to other observations in ADHD, schizophrenia and autism investigations, when measuring drug effect and when screening hearing. SensoDetect’s unique and globally patented technology reduces the financial impact on healthcare and society and gives patients and their relatives a faster and safer result. Read more about SensoDetect BERA at our website, www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychatric #testing #neurodivergent #npf #medtech #sensodetect

MENA. SensoDetect appoints Head of Research for the MENA region SensoDetect’s success in Saudi Arabia has seen a sharp increase in interest from the MENA region’s health sector. In order to meet increased demand and to secure our presence also clinically and medically, we have employed a very competent and experienced doctor. With Dr. Atwa, we can reach more hospitals and clinics throughout the Middle East and North Africa more quickly. A region where we predict up to 2 million measurements per year. Read more about SensoDetect BERA at our website, www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychiatric #testing #neurodivergent #npf #medtech #sensodetect

MED TECH AI. SensoDetect AB is a Med Tech AI company listed on the Spotlight stock market. The company was founded in Lund, Sweden in 2005, based on more than 30 years of research in clinical psychoacoustics at the Department of Neuroscience at Lund University. Initially, the focus was on patients with schizophrenia, as it is a disease where auditory hallucinations are a common symptom, but today the company offers several other services in the product areas of diagnostics, medication and health. Read more about SensoDetect BERA at our website, www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychatric #testing #neurodivergent #npf #medtech #sensodetect

RELIEF. A sense of relief and understanding can mean a lot to a person with mental illness. No one should have to go through lengthy processes to get their diagnosis. Our diagnostic tool, SensoDetect BERA, makes a more efficient process for making safe diagnoses and giving patients the care they need, all over the world. Read more about SensoDetect BERA at our website, www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychatric #testing #neurodivergent #npf #medtech #sensodetect

TRENDY. "People get ADHD just because it's trendy", did you ever hear that? This is a common myth about ADHD, based on ignorance. It is easy to recognize symptoms that are compatible with ADHD, such as impulsivity, hyperactivity and concentration difficulties, but to be diagnosed with ADHD, they must cause such great problems that everyday life becomes difficult to cope with. In other words, just because we recognize ourselves does not mean that we have a disability. ADHD is not a fad, it is a very real problem that is experienced every day for a long time. Read more about mental health at our website, www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychatric #testing #neurodivergent #npf #medtech #sensodetect

BERA. Diagnoses of mental illness are related to different parts of the brain. SensoDetect BERA stimulates the patient's brain with unique clicking sounds through headphones, while brainstem activity is recorded via five electrodes. The test is carried out in a dark and quiet room and takes 15-30 minutes with trained and empathetic healthcare staff. We still offer tests from our offices in Lund, Malmö in Sweden. See more about SensoDetect BERA, www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychatric #testing #neurodivergent #npf #medtech #sensodetect

THE TEST. A 15-30 minute SensoDetect® BERA test shortens care queues through screening, facilitates and validates a diagnosis and helps find the right medicine in the right dose during treatment. Our goal is for more people to get the right diagnosis in time and the right support on a larger scale, at a higher speed, all over the world. See more about the test , www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychatric #testing #neurodivergent #npf #medtech #sensodetect

OBJECTIVE. What if healthcare professionals, psychologists, doctors and educators who already work dedicatedly on a daily basis to help people with mental illness, could get the help they need? An objective diagnostic support that provides the right information faster, that both saves time and provides a measurable, objective result? Imagine if more people could get support on a larger scale, at a higher speed, all over the world. What if we can get more people talking about SensoDetect BERA as an obvious way to reduce care queues, care costs and offer a clinic environment where everyone feels safe and cared for? That's what we work for, every day at SensoDetect. Welcome to Sensodetect. See more about our method on our website, www.sensodetect.com #mentalhealth #adhd #autism #technology #diagnosis #psychatric #testing #neurodivergent #npf #medtech #sensodetect